NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Publications

Publications published since 1981 or in press by Bjarne Bogen

123 publications found

Publications 2013

  1. Gunnarsen KS, Kristinsson SG, Justesen S, Frigstad T, Buus S, Bogen B, Sandlie I, Løset GÅ (2013)
    Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display
    Sci Rep, 3, 1162
    PubMed 23362461
  2. Heimberger T, Andrulis M, Riedel S, Stühmer T, Schraud H, Beilhack A, Bumm T, Bogen B, Einsele H, Bargou RC, Chatterjee M (2013)
    The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
    Br J Haematol, 160 (4), 465-76
    PubMed 23252346

Publications 2012

  1. Berge T, Grønningsæter IH, Lorvik KB, Abrahamsen G, Granum S, Sundvold-Gjerstad V, Corthay A, Bogen B, Spurkland A (2012)
    SH2D2A modulates T cell mediated protection to a B cell derived tumor in transgenic mice
    PLoS One, 7 (10), e48239
    PubMed 23144743
  2. Fredriksen AB, Sandlie I, Bogen B (2012)
    Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells
    Front Oncol, 2, 154
    PubMed 23115759
  3. Hofgaard PO, Jodal HC, Bommert K, Huard B, Caers J, Carlsen H, Schwarzer R, Schünemann N, Jundt F, Lindeberg MM, Bogen B (2012)
    A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease
    PLoS One, 7 (12), e51892
    PubMed 23284805
  4. Haabeth OA, Bogen B, Corthay A (2012)
    A model for cancer-suppressive inflammation
    Oncoimmunology, 1 (7), 1146-1155
    PubMed 23170261
  5. Lorvik KB, Bogen B, Corthay A (2012)
    Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice
    Blood, 119 (9), 2176-7
    PubMed 22383793
  6. Nilssen NR, Frigstad T, Pollmann S, Roos N, Bogen B, Sandlie I, Løset GÅ (2012)
    DeltaPhage--a novel helper phage for high-valence pIX phagemid display
    Nucleic Acids Res, 40 (16), e120
    PubMed 22539265
  7. Rasmussen IB, Oynebråten I, Høydahl LS, Flobakk M, Lunde E, Michaelsen TE, Bogen B, Sandlie I (2012)
    CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses
    Protein Eng Des Sel, 25 (3), 89-96
    PubMed 22233931
  8. Riedel SS, Mottok A, Brede C, Bäuerlein CA, Jordán Garrote AL, Ritz M, Mattenheimer K, Rosenwald A, Einsele H, Bogen B, Beilhack A (2012)
    Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma
    PLoS One, 7 (12), e52398
    PubMed 23300660
  9. Spång HC, Braathen R, Bogen B (2012)
    Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells
    PLoS One, 7 (9), e45393
    PubMed 23028981
  10. Øynebråten I, Løvås TO, Thompson K, Bogen B (2012)
    Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccine
    Scand J Immunol, 75 (4), 379-88
    PubMed 21955209

Publications 2011

  1. Bogen B (2011)
    Lymphoma invisibility-vaccination-attack?
    Blood, 117 (5), 1437-8
    PubMed 21292780
  2. Bogen B (2011)
    Welcome to the 40th Scandinavian Society for Immunology meeting at Geilo, Norway
    Scand. J. Immunol., 73 (4), 267
  3. Corthay A, Lorvik KB, Bogen B (2011)
    Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
    Scand J Immunol, 73 (6), 527-30
    PubMed 21388431
  4. Crozat K, Tamoutounour S, Vu Manh TP, Fossum E, Luche H, Ardouin L, Guilliams M, Azukizawa H, Bogen B, Malissen B, Henri S, Dalod M (2011)
    Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8?+ type
    J Immunol, 187 (9), 4411-5
    PubMed 21948982
  5. Follin-Arbelet V, Hofgaard PO, Hauglin H, Naderi S, Sundan A, Blomhoff R, Bogen B, Blomhoff HK (2011)
    Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model
    BMC Cancer, 11, 301
    PubMed 21767374
  6. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
    Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
    Eur J Haematol, 86 (5), 385-95
    PubMed 21332794
  7. Haabeth OA, Lorvik KB, Hammarström C, Donaldson IM, Haraldsen G, Bogen B, Corthay A (2011)
    Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
    Nat Commun, 2, 240
    PubMed 21407206
  8. Løset GÅ, Bogen B, Sandlie I (2011)
    Expanding the versatility of phage display I: efficient display of peptide-tags on protein VII of the filamentous phage
    PLoS One, 6 (2), e14702
    PubMed 21390217
  9. Løset GÅ, Roos N, Bogen B, Sandlie I (2011)
    Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage
    PLoS One, 6 (2), e17433
    PubMed 21390283

Publications 2010

  1. Gunnarsen KS, Lunde E, Kristiansen PE, Bogen B, Sandlie I, Løset GÅ (2010)
    Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA
    BMC Biotechnol, 10, 8
    PubMed 20128915
  2. Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B (2010)
    The idiotype connection: linking infection and multiple sclerosis
    Trends Immunol, 31 (2), 56-62
    PubMed 19962346
  3. Jacobsen JT, Lunde E, Sundvold-Gjerstad V, Munthe LA, Bogen B (2010)
    The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation
    Immunol Cell Biol, 88 (5), 515-22
    PubMed 20066000
  4. Lunde E, Løset GÅ, Bogen B, Sandlie I (2010)
    Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins
    BMC Biotechnol, 10, 61
    PubMed 20735812
  5. Ruffini PA, Grødeland G, Fredriksen AB, Bogen B (2010)
    Human chemokine MIP1? increases efficiency of targeted DNA fusion vaccines
    Vaccine, 29 (2), 191-9
    PubMed 21055498

Publications 2009

  1. Bogen B, Ruffini P (2009)
    Review: to what extent are T cells tolerant to immunoglobulin variable regions?
    Scand J Immunol, 70 (6), 526-30
    PubMed 19906193
  2. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B (2009)
    Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells
    Cancer Res, 69 (14), 5901-7
    PubMed 19567679
  3. Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R, Munthe LA, Bogen B (2009)
    Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems
    Am J Pathol, 174 (4), 1358-67
    PubMed 19286564

Publications 2008

  1. Flobakk M, Rasmussen IB, Lunde E, Frigstad T, Berntzen G, Michaelsen TE, Bogen B, Sandlie I (2008)
    Processing of an antigenic sequence from IgG constant domains for presentation by MHC class II
    J Immunol, 181 (10), 7062-72
    PubMed 18981126
  2. Kolltveit KM, Granum S, Aasheim HC, Forsbring M, Sundvold-Gjerstad V, Dai KZ, Molberg O, Schjetne KW, Bogen B, Shapiro VS, Johansen FE, Schenck K, Spurkland A (2008)
    Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level
    Mol Immunol, 45 (8), 2380-90
    PubMed 18160104
  3. Tunheim G, Schjetne KW, Rasmussen IB, Sollid LM, Sandlie I, Bogen B (2008)
    Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes
    Int Immunol, 20 (3), 295-306
    PubMed 18252695

Publications 2007

  1. Fredriksen AB, Bogen B (2007)
    Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences
    Blood, 110 (6), 1797-805
    PubMed 17540847
  2. Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
    A VH4-34+ myeloma protein with weak autoreactivity
    Haematologica, 92 (5), 690-3
    PubMed 17488696
  3. Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T (2007)
    T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG
    Scand J Immunol, 66 (4), 393-401
    PubMed 17850583
  4. Løset GÅ, Lunde E, Bogen B, Brekke OH, Sandlie I (2007)
    Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance
    Protein Eng Des Sel, 20 (9), 461-72
    PubMed 17925331
  5. Ráki M, Schjetne KW, Stamnaes J, Molberg Ø, Jahnsen FL, Issekutz TB, Bogen B, Sollid LM (2007)
    Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells
    Scand J Immunol, 65 (3), 213-20
    PubMed 17309775
  6. Schjetne KW, Fredriksen AB, Bogen B (2007)
    Delivery of antigen to CD40 induces protective immune responses against tumors
    J Immunol, 178 (7), 4169-76
    PubMed 17371973
  7. Tunheim G, Thompson KM, Fredriksen AB, Espevik T, Schjetne KW, Bogen B (2007)
    Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates
    Vaccine, 25 (24), 4723-34
    PubMed 17499405
  8. Zangani MM, Frøyland M, Qiu GY, Meza-Zepeda LA, Kutok JL, Thompson KM, Munthe LA, Bogen B (2007)
    Lymphomas can develop from B cells chronically helped by idiotype-specific T cells
    J Exp Med, 204 (5), 1181-91
    PubMed 17485509

Publications 2006

  1. Bogen B, Ruffini PA, Corthay A, Fredriksen AB, Frøyland M, Lundin K, Røsjø E, Thompson K, Massaia M (2006)
    Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research
    Haematologica, 91 (7), 941-8
    PubMed 16818282
  2. Fredriksen AB, Sandlie I, Bogen B (2006)
    DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells
    Mol Ther, 13 (4), 776-85
    PubMed 16414309
  3. Husebye H, Halaas Ø, Stenmark H, Tunheim G, Sandanger Ø, Bogen B, Brech A, Latz E, Espevik T (2006)
    Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity
    EMBO J, 25 (4), 683-92
    PubMed 16467847
  4. Kjeken R, Bogen B, Mathiesen I (2006)
    [DNA--the future in vaccine technology?]
    Tidsskr Nor Laegeforen, 126 (22), 2964-8
    PubMed 17117196

Publications 2005

  1. Corthay A, Skovseth DK, Lundin KU, Røsjø E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B (2005)
    Primary antitumor immune response mediated by CD4+ T cells
    Immunity, 22 (3), 371-83
    PubMed 15780993
  2. Holmøy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F (2005)
    Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells
    Eur J Immunol, 35 (6), 1786-94
    PubMed 15864781
  3. Munthe LA, Corthay A, Os A, Zangani M, Bogen B (2005)
    Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells
    J Immunol, 175 (4), 2391-400
    PubMed 16081810
  4. Schjetne KW, Thommesen JE, Fredriksen AB, Lunde E, Sandlie I, Bogen B (2005)
    Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes
    Eur J Immunol, 35 (11), 3142-52
    PubMed 16184515
  5. Tunheim G, Schjetne KW, Fredriksen AB, Sandlie I, Bogen B (2005)
    Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes
    J Leukoc Biol, 77 (3), 303-10
    PubMed 15576418

Publications 2004

  1. Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
    Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
    Cancer Immunol Immunother, 53 (9), 759-69
    PubMed 15088126
  2. Dembic Z, Hofgaard PO, Omholt H, Bogen B (2004)
    Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice
    Scand J Immunol, 60 (1-2), 143-52
    PubMed 15238083
  3. Etokebe GE, Abrahamsen TG, Bogen B, Spurkland A (2004)
    Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography
    Scand J Immunol, 59 (5), 496-503
    PubMed 15140060
  4. Lundin KU, Screpanti V, Omholt H, Hofgaard PO, Yagita H, Grandien A, Bogen B (2004)
    CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo
    Cancer Immunol Immunother, 53 (12), 1135-45
    PubMed 15696611
  5. Munthe LA, Os A, Zangani M, Bogen B (2004)
    MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production
    J Immunol, 172 (12), 7476-84
    PubMed 15187126
  6. Ruffini PA, Biragyn A, Coscia M, Harvey LK, Cha SC, Bogen B, Kwak LW (2004)
    Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis
    J Leukoc Biol, 76 (1), 77-85
    PubMed 15075363
  7. Tjelle TE, Corthay A, Lunde E, Sandlie I, Michaelsen TE, Mathiesen I, Bogen B (2004)
    Monoclonal antibodies produced by muscle after plasmid injection and electroporation
    Mol Ther, 9 (3), 328-36
    PubMed 15006599

Publications 2003

  1. Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, Schenck K, Bogen B, Dembic Z (2003)
    Liver metastasis of cancer facilitated by chemokine receptor CCR6
    Scand J Immunol, 57 (6), 534-44
    PubMed 12791091
  2. Lundin KU, Hofgaard PO, Omholt H, Munthe LA, Corthay A, Bogen B (2003)
    Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies
    Blood, 102 (2), 605-12
    PubMed 12649166
  3. Schjetne KW, Gundersen HT, Iversen JG, Thompson KM, Bogen B (2003)
    Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responses
    Eur J Immunol, 33 (11), 3101-8
    PubMed 14579278
  4. Schjetne KW, Thompson KM, Nilsen N, Flo TH, Fleckenstein B, Iversen JG, Espevik T, Bogen B (2003)
    Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target
    J Immunol, 171 (1), 32-6
    PubMed 12816980

Publications 2002

  1. Bogen B (2002)
    A mouse model for immunotherapy of myeloma
    Hematol J, 3 (5), 224-9
    PubMed 12391539
  2. Lunde E, Lauvrak V, Rasmussen IB, Schjetne KW, Thompson KM, Michaelsen TE, Brekke OH, Sollid LM, Bogen B, Sandlie I (2002)
    Troybodies and pepbodies
    Biochem Soc Trans, 30 (4), 500-6
    PubMed 12196123
  3. Lunde E, Western KH, Rasmussen IB, Sandlie I, Bogen B (2002)
    Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies
    J Immunol, 168 (5), 2154-62
    PubMed 11859101
  4. Schjetne KW, Thompson KM, Aarvak T, Fleckenstein B, Sollid LM, Bogen B (2002)
    A mouse C kappa-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation
    Int Immunol, 14 (12), 1423-30
    PubMed 12456590

Publications 2001

  1. Dembic Z, Røttingen JA, Dellacasagrande J, Schenck K, Bogen B (2001)
    Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level
    Blood, 97 (9), 2808-14
    PubMed 11313275
  2. Lund E, Rasmussen IB, Western KH, Eidem JK, Sandlie I, Bogen B (2001)
    "Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cells
    Int Rev Immunol, 20 (5), 647-73
    PubMed 11890617
  3. Lunde E, Rasmussen IB, Eidem JK, Gregers TF, Western KH, Bogen B, Sandlie I (2001)
    'Troy-bodies': antibodies as vector proteins for T cell epitopes
    Biomol Eng, 18 (3), 109-16
    PubMed 11566602
  4. McAdam SN, Fleckenstein B, Rasmussen IB, Schmid DG, Sandlie I, Bogen B, Viner NJ, Sollid LM (2001)
    T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation
    J Exp Med, 193 (11), 1239-46
    PubMed 11390431
  5. Rasmussen IB, Lunde E, Michaelsen TE, Bogen B, Sandlie I (2001)
    The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination
    Proc Natl Acad Sci U S A, 98 (18), 10296-301
    PubMed 11517321

Publications 2000

  1. Bogen B, Schenck K, Munthe LA, Dembic Z (2000)
    Deletion of idiotype (Id)-specific T cells in multiple myeloma
    Acta Oncol, 39 (7), 783-8
    PubMed 11145433
  2. Dembic Z, Schenck K, Bogen B (2000)
    Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells
    Proc Natl Acad Sci U S A, 97 (6), 2697-702
    PubMed 10706628
  3. Eidem JK, Rasmussen IB, Lunde E, Gregers TF, Rees AR, Bogen B, Sandlie I (2000)
    Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation
    J Immunol Methods, 245 (1-2), 119-31
    PubMed 11042289

Publications 1999

  1. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A (1999)
    The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
    J Exp Med, 190 (7), 1025-32
    PubMed 10510092
  2. Lunde E, Munthe LA, Vabø A, Sandlie I, Bogen B (1999)
    Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells
    Nat Biotechnol, 17 (7), 670-5
    PubMed 10404160
  3. Munthe LA, Kyte JA, Bogen B (1999)
    Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo
    Eur J Immunol, 29 (12), 4043-52
    PubMed 10602015

Publications 1998

  1. Bogen B (1998)
    [Kaspase or caspase?]
    Tidsskr Nor Laegeforen, 118 (30), 4790
    PubMed 9914770
  2. Dembic Z, Munthe LA, Schenck K, Mueller C, Bogen B (1998)
    Transient overexpression of CD4 enhances allelic exclusion of T-cell receptor (TCR) alpha chains and promotes positive selection of class II-restricted TCR-transgenic thymocytes
    Mol Immunol, 35 (1), 23-38
    PubMed 9683261
  3. Engel H, Bogen B, Müller U, Andersson J, Rolink A, Weiss S (1998)
    Expression level of a transgenic lambda2 chain results in isotype exclusion and commitment to B1 cells
    Eur J Immunol, 28 (8), 2289-99
    PubMed 9710207
  4. Lauritzsen GF, Hofgaard PO, Schenck K, Bogen B (1998)
    Clonal deletion of thymocytes as a tumor escape mechanism
    Int J Cancer, 78 (2), 216-22
    PubMed 9754655
  5. Sim BC, Aftahi N, Reilly C, Bogen B, Schwartz RH, Gascoigne NR, Lo D (1998)
    Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor alpha-chain locus
    Curr Biol, 8 (12), 701-4
    PubMed 9637921

Publications 1997

  1. Bogen B (1997)
    [University medicine in Silicon Valley]
    Tidsskr Nor Laegeforen, 117 (11), 1641-2
    PubMed 9198951
  2. Lunde E, Bogen B, Sandlie I (1997)
    Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells
    Mol Immunol, 34 (16-17), 1167-76
    PubMed 9566764
  3. Reichardt VL, Okada CY, Stockerl-Goldstein KE, Bogen B, Levy R (1997)
    Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma
    Biol Blood Marrow Transplant, 3 (3), 157-63
    PubMed 9310193

Publications 1996

  1. Blichfeldt E, Munthe LA, Røtnes JS, Bogen B (1996)
    Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor
    Eur J Immunol, 26 (12), 2876-84
    PubMed 8977280
  2. Bogen B (1996)
    Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma
    Eur J Immunol, 26 (11), 2671-9
    PubMed 8921954
  3. Bot A, Nangpal A, Pricop L, Bogen B, Kaushik A, Bona CA (1996)
    V lambda-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different VH genes
    Mol Immunol, 33 (17-18), 1359-68
    PubMed 9171895
  4. Munthe LA, Blichfeldt E, Sollien A, Dembic Z, Bogen B (1996)
    T cells with two Tcrbeta chains and reactivity to both MHC/idiotypic peptide and superantigen
    Cell Immunol, 170 (2), 283-90
    PubMed 8660828

Publications 1995

  1. Bogen B, Munthe L, Sollien A, Hofgaard P, Omholt H, Dagnaes F, Dembic Z, Lauritzsen GF (1995)
    Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies
    Eur J Immunol, 25 (11), 3079-86
    PubMed 7489746
  2. Dybwad A, Bogen B, Natvig JB, Førre O, Sioud M (1995)
    Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera
    Clin Exp Immunol, 102 (2), 438-42
    PubMed 7586703
  3. Munthe LA, Sollien A, Dembic Z, Bogen B (1995)
    Preferential positive selection of T lymphocytes which express two different TCR alpha chains, an endogenous and a transgenic
    Scand J Immunol, 42 (6), 651-61
    PubMed 8552989

Publications 1994

  1. Dembi? Z, Weiss S, Bogen B (1994)
    Thymic selection of immunoglobulin idiotype specific T-cells
    Thymus, 22 (3), 141-52
    PubMed 7940642
  2. Lauritzsen GF, Weiss S, Dembic Z, Bogen B (1994)
    Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors
    Proc Natl Acad Sci U S A, 91 (12), 5700-4
    PubMed 7911244
  3. Røtnes JS, Bogen B (1994)
    Ca2+ mobilization in physiologically stimulated single T cells gradually increases with peptide concentration (analog signaling)
    Eur J Immunol, 24 (4), 851-8
    PubMed 8149956

Publications 1993

  1. Bogen B, Dembic Z, Weiss S (1993)
    Clonal deletion of specific thymocytes by an immunoglobulin idiotype
    EMBO J, 12 (1), 357-63
    PubMed 8428591
  2. Bogen B, Gleditsch L, Teig A (1993)
    T-cell receptor alpha haplotype influences V alpha epitope expression on both cortisone-resistant thymocytes and lymph node T cells
    Scand J Immunol, 37 (6), 690-5
    PubMed 7686302
  3. Bogen B, Weiss S (1993)
    Processing and presentation of idiotypes to MHC-restricted T cells
    Int Rev Immunol, 10 (4), 337-55
    PubMed 8294847
  4. Lauritzsen GF, Bogen B (1993)
    The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells
    Cell Immunol, 148 (1), 177-88
    PubMed 8098665
  5. Lauritzsen GF, Weiss S, Bogen B (1993)
    Anti-tumour activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo
    Scand J Immunol, 37 (1), 77-85
    PubMed 8418475

Publications 1992

  1. Bogen B, Gleditsch L, Weiss S, Dembic Z (1992)
    Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities
    Eur J Immunol, 22 (3), 703-9
    PubMed 1547816
  2. Gleditsch L, Bogen B (1992)
    A Tcra congenic mouse: V alpha epitope expression is influenced by both Tcra haplotypes and background genes
    Immunogenetics, 35 (3), 153-60
    PubMed 1371498
  3. Snodgrass HR, Fisher AM, Bruyns E, Bogen B (1992)
    Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences
    Eur J Immunol, 22 (8), 2169-72
    PubMed 1379189

Publications 1991

  1. Bogen B, Weiss S (1991)
    A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression
    Eur J Immunol, 21 (10), 2391-5
    PubMed 1915552
  2. Lauritzsen GF, Bogen B (1991)
    Idiotype-specific, major histocompatibility complex restricted T cells are of both Th1 and Th2 type
    Scand J Immunol, 33 (6), 647-56
    PubMed 1675480
  3. Weiss S, Bogen B (1991)
    MHC class II-restricted presentation of intracellular antigen
    Cell, 64 (4), 767-76
    PubMed 1847667

Publications 1990

  1. Bogen B, Lauritzsen GF, Weiss S (1990)
    A stimulatory monoclonal antibody detecting T cell receptor diversity among idiotype-specific, major histocompatibility complex-restricted T cell clones
    Eur J Immunol, 20 (10), 2359-62
    PubMed 1700755
  2. Gleditsch L, Snodgrass R, Bogen B (1990)
    No recombinations between Tcra-V and Tcra-C gene segments in 669 backcross mice
    Immunogenetics, 32 (5), 297-303
    PubMed 1979062

Publications 1989

  1. Bogen B (1989)
    Monoclonal antibodies specific for variable and constant domains of murine lambda chains
    Scand J Immunol, 29 (3), 273-9
    PubMed 2497510
  2. Bogen B, Lambris JD (1989)
    Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule
    EMBO J, 8 (7), 1947-52
    PubMed 2792076
  3. Weiss S, Bogen B (1989)
    B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells
    Proc Natl Acad Sci U S A, 86 (1), 282-6
    PubMed 2492101

Publications 1988

  1. Bogen B, Weiss S (1988)
    B lymphoma cells process and present their endogenous IG: implications for network theory
    Adv Exp Med Biol, 237, 877-82
    PubMed 3267071

Publications 1986

  1. Bogen B, Malissen B, Haas W (1986)
    Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules
    Eur J Immunol, 16 (11), 1373-8
    PubMed 3096740
  2. Bogen B, Snodgrass R, Briand JP, Hannestad K (1986)
    Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region
    Eur J Immunol, 16 (11), 1379-84
    PubMed 3096741

Publications 1985

  1. Bogen B (1985)
    Dominant suppressive effect of the silent Eb alpha allele on an in vivo T helper cell response under Ed beta Ed alpha region-linked immune response gene control
    Eur J Immunol, 15 (10), 1033-7
    PubMed 2932337
  2. Bogen B, Jørgensen T, Hannestad K (1985)
    T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region
    Eur J Immunol, 15 (3), 278-81
    PubMed 2579823
  3. Jørgensen T, Bogen B, Hannestad K (1985)
    H-2-linked Ir genes have a striking influence on the immunogenicity of idiotopes of myeloma protein 315 for T helper cells
    Scand J Immunol, 21 (2), 183-7
    PubMed 3156401

Publications 1984

  1. Bogen B (1984)
    H-2 and non-H-2 genes complement each other for a carrier (idiotype)-specific Th response
    Immunogenetics, 20 (4), 453-7
    PubMed 6237990
  2. Bogen B (1984)
    Antibody responses to lambda 1J558 and lambda 2315 light chains. Specificity and genetic regulation
    Scand J Immunol, 20 (5), 413-24
    PubMed 6209791
  3. Bogen B, Hannestad K (1984)
    Determinant-specific regulation of T helper cell responses to murine lambda light chains by both H-2 and non-H-2 genes
    Eur J Immunol, 14 (2), 158-63
    PubMed 6199213
  4. Bogen B, Hannestad K (1984)
    Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits
    Mol Immunol, 21 (7), 653-61
    PubMed 6205254

Publications 1983

  1. Bogen B, Jørgensen T, Hannestad K (1983)
    Recognition of lambda 1 and lambda 2 murine light chains by carrier-specific isologous T helper cells; effect of L-H chain assembly
    Eur J Immunol, 13 (5), 353-9
    PubMed 6189725
  2. Jørgensen T, Bogen B, Hannestad K (1983)
    T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315)
    J Exp Med, 158 (6), 2183-8
    PubMed 6227679

Publications 1982

  1. Marhaug G, Gaudernack G, Bogen B, Husby G (1982)
    Monoclonal hybridoma antibodies to human amyloid related protein SAA
    Clin Exp Immunol, 50 (2), 390-6
    PubMed 7151332

Publications 1981

  1. Myhre ES, Waldum HL, Burhol PG, Bogen B, Bostad L, Wesenberg F (1981)
    [Acquired idiopathic hypogammaglobulinemia. A patient protocol]
    Tidsskr Nor Laegeforen, 101 (7), 459-61
    PubMed 7209936
 
[962 visits]
>> Go back   >> Print this page   >> E-mail this page